Carclo plc Result of AGM (8363I)
02 September 2016 - 11:49AM
UK Regulatory
TIDMCAR
RNS Number : 8363I
Carclo plc
02 September 2016
For immediate release 2 September 2016
Carclo plc
Result of AGM Resolutions
Carclo plc announces that all resolutions proposed at the Annual
General Meeting yesterday were passed on a show of hands.
Resolution 3, set out in the Notice of the AGM, relating to the
declaration of a final dividend, had become redundant in the light
of the Company's announcement made on 31 August 2016, and was
therefore, with the approval of the meeting, not proposed to the
shareholders.
In accordance with Listing Rule 9.6.2, copies of the resolutions
passed as special business will be submitted to the UK Listing
Authority via the National Storage Mechanism, which can be accessed
at www.morningstar.co.uk.
The items of special business approved at the AGM were:
(i) authority to allot shares pursuant to Section 551 of the Companies Act 2006.
(ii) Disapplication of pre-emption rights upon the allotment of
equity securities for cash pursuant to Section 570 of the Companies
Act 2006.
(iii) authority to make market purchases of shares pursuant to
Section 701 of the Companies Act 2006.
(iv) approval to call general meetings (other than annual
general meetings) on 14 clear days' notice.
A half year trading update will be issued during the week
commencing 10 October 2016.
- ENDS -
Enquiries:
Carclo plc 01924 268040
Chris Malley, Chief Executive
Robert Brooksbank, Finance Director
Weber Shandwick Financial 020 7067 0700
Nick Oborne
Notes to editors
Carclo plc is a public company whose shares are quoted on the
London Stock Exchange.
Carclo's strategy is to develop and expand its key manufacturing
assets where there remain significant further opportunities to
drive value. To enhance profit margins and support customers the
Group has been investing in lower cost regions and new
technologies.
Approximately three fifths of Group revenues are derived from
the supply of fine tolerance, injection moulded plastic components,
mainly for medical products. The balance of revenue is derived
mainly from the design and supply of specialised injection moulded
LED based lighting systems to the low volume premium automotive
industry.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSSAFSEFMSELU
(END) Dow Jones Newswires
September 02, 2016 06:49 ET (10:49 GMT)